📣 VC round data is live. Check it out!

Japan Lifeline Valuation Multiples

Discover Japan Lifeline's revenue and EBITDA valuation multiples and investment history, alongside public comparables like NeuroPace, Sofwave Medical, Beta Bionics, Tactile Medical and more.

Japan Lifeline Overview

About Japan Lifeline

Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.


Founded

1981

HQ

Japan

Employees

1.2K

Website

jll.co.jp

Financials (LTM)

Revenue: $380M
EBITDA: $89M

EV

$502M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Japan Lifeline Financials

Japan Lifeline reported last 12-month revenue of $380M and EBITDA of $89M.

In the same LTM period, Japan Lifeline generated $224M in gross profit, $89M in EBITDA, and $59M in net income.

Revenue (LTM)


Japan Lifeline P&L

In the most recent fiscal year, Japan Lifeline reported revenue of $355M and EBITDA of $87M.

Japan Lifeline is profitable as of last fiscal year, with gross margin of 60%, EBITDA margin of 24%, and net margin of 16%.

See analyst estimates for Japan Lifeline
LTMLast FY202320242025202620272028
Revenue$380M$355M$322M$346M$372M
Gross Profit$224M$214M$192M$209M$222M
Gross Margin59%60%60%60%60%
EBITDA$89M$87M$75M$84M$90M
EBITDA Margin24%24%23%24%24%
EBIT Margin21%22%21%22%21%
Net Profit$59M$58M$46M$56M$59M
Net Margin15%16%14%16%16%

Financial data powered by Morningstar, Inc.

Japan Lifeline Stock Performance

Japan Lifeline has current market cap of $561M, and enterprise value of $502M.

Market Cap Evolution


Japan Lifeline's stock price is $8.00.

Japan Lifeline share price decreased by 4.0% in the last 30 days, and by 15.0% in the last year.

Japan Lifeline has an EPS (earnings per share) of $0.83.

See more trading valuation data for Japan Lifeline
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$502M$561M-1.6%-4.0%-7.2%-15.0%$0.83

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Japan Lifeline Valuation Multiples

Japan Lifeline trades at 1.3x EV/Revenue multiple, and 5.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Japan Lifeline

EV / Revenue (LTM)


Japan Lifeline Financial Valuation Multiples

As of June 3, 2026, Japan Lifeline has market cap of $561M and EV of $502M.

Japan Lifeline has a P/E ratio of 9.6x.

LTMLast FY202320242025202620272028
EV/Revenue1.3x1.4x1.6x1.4x1.3x
EV/EBITDA5.6x5.8x6.7x6.0x5.6x
EV/EBIT6.3x6.5x7.4x6.7x6.3x
EV/Gross Profit2.2x2.3x2.6x2.4x2.3x
P/E9.6x9.6x12.2x10.1x9.5x
EV/FCF12.9x10.7x13.8x11.8x12.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Japan Lifeline Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Japan Lifeline Margins & Growth Rates

Japan Lifeline grew revenue by 7% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, Japan Lifeline reported gross margin of 60%, EBITDA margin of 24%, and net margin of 16%.

See estimated margins and future growth rates for Japan Lifeline

Japan Lifeline Margins

Last FY202420252026202720282029
Gross Margin60%60%60%58%
EBITDA Margin24%24%24%22%
EBIT Margin22%22%21%20%
Net Margin16%16%16%14%
FCF Margin13%12%11%10%

Japan Lifeline Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%7%7%4%
Gross Profit Growth5%9%6%0%
EBITDA Growth5%13%7%(7%)
EBIT Growth4%10%6%(5%)
Net Profit Growth2%20%7%(7%)
FCF Growth(17%)17%(3%)(7%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Japan Lifeline Operational KPIs

Japan Lifeline's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Japan Lifeline's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Japan Lifeline's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Japan Lifeline
LTMLast FY202320242025202620272028
Rule of 4027%25%---
Bessemer Rule of X31%31%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-1%1%1%1%
G&A Expenses to Revenue-2%2%2%2%
R&D Expenses to Revenue5%5%5%5%5%
Opex to Revenue-39%39%39%37%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Japan Lifeline Competitors

Japan Lifeline competitors include NeuroPace, Sofwave Medical, Beta Bionics, Tactile Medical, Bioventus, Polynovo, Cytek Biosciences, Cerus, IBA Group and Mesa Laboratories.

Most Japan Lifeline public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
NeuroPace5.7x5.7x(114.3x)(86.6x)
Sofwave Medical6.0x-68.7x-
Beta Bionics3.8x3.3x(7.1x)(5.9x)
Tactile Medical1.4x1.4x10.6x10.1x
Bioventus1.4x1.3x6.8x6.7x
Polynovo5.9x5.0x72.0x57.2x
Cytek Biosciences1.5x1.5x(463.4x)(186.0x)
Cerus2.4x2.3x58.8x40.6x

This data is available for Pro users. Sign up to see all Japan Lifeline competitors and their valuation data.

Start Free Trial

Investments by Japan Lifeline

Japan Lifeline has invested in 2 companies to date.

Latest investment by Japan Lifeline was on June 28th 2022. Japan Lifeline invested in Metcela in their $14M Series C round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Japan Lifeline

Metcela
Metcela
Metcela
AI Medical Service
Description
-
-
-
AI Medical Service is a Japanese startup developing AI software incorporating expertise from endoscopic specialists. The technology aids global advancements in endoscopic diagnostics and procedures.
HQ CountryJapanJapanJapanJapan
HQ City
-
-
-
Tokyo
Deal Date28 Jun 20224 Jan 202118 Mar 20204 Oct 2019
RoundSeries CSeries BSeries BSeries B
Raised$14M$13M$4M$43M
InvestorsCyberdyne; Japan Lifeline; Reazon Holdings; Sony Innovation FundAlfresa Holdings; Dai-ichi Life; Eight Roads Ventures; F-Prime; Japan Lifeline; KSP; MAKOTO Capital; Sony Innovation Fund; Tsukuba Exceed Fund; UTEC-The University of Tokyo Edge Capital PartnersJapan Lifeline; Sony Innovation Fund; Tsukuba Exceed FundAflac Global Ventures; Daiwa Corporate Investment; Globis Capital Partners; Innovation Growth Ventures; Japan Lifeline; Japan Post Capital; Ryoyo Electro Corporation; SMBC Venture Capital; Sony Innovation Fund; SparX Group; World Innovation Lab
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Japan Lifeline investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Japan Lifeline

When was Japan Lifeline founded?Japan Lifeline was founded in 1981.
Where is Japan Lifeline headquartered?Japan Lifeline is headquartered in Japan.
How many employees does Japan Lifeline have?As of today, Japan Lifeline has over 1K employees.
Who is the CEO of Japan Lifeline?Japan Lifeline's CEO is Keisuke Suzuki.
Is Japan Lifeline publicly listed?Yes, Japan Lifeline is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Japan Lifeline?Japan Lifeline trades under 7575 ticker.
When did Japan Lifeline go public?Japan Lifeline went public in 1997.
Who are competitors of Japan Lifeline?Japan Lifeline main competitors include NeuroPace, Sofwave Medical, Beta Bionics, Tactile Medical, Bioventus, Polynovo, Cytek Biosciences, Cerus, IBA Group, Mesa Laboratories.
What is the current market cap of Japan Lifeline?Japan Lifeline's current market cap is $561M.
What is the current revenue of Japan Lifeline?Japan Lifeline's last 12 months revenue is $380M.
What is the current revenue growth of Japan Lifeline?Japan Lifeline revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Japan Lifeline?Current revenue multiple of Japan Lifeline is 1.3x.
What is the current EBITDA of Japan Lifeline?Japan Lifeline's last 12 months EBITDA is $89M.
What is Japan Lifeline's EBITDA margin?Japan Lifeline's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of Japan Lifeline?Current EBITDA multiple of Japan Lifeline is 5.6x.
What is the current FCF of Japan Lifeline?Japan Lifeline's last 12 months FCF is $39M.
What is Japan Lifeline's FCF margin?Japan Lifeline's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of Japan Lifeline?Current FCF multiple of Japan Lifeline is 12.9x.
How many companies Japan Lifeline has acquired to date?Japan Lifeline hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Japan Lifeline has invested to date?As of June 2026, Japan Lifeline has invested in 2 companies.
What was the last Japan Lifeline investment?On 28th June 2022 Japan Lifeline invested in Metcela, participating in a $14M Series C round, alongside Cyberdyne, Reazon Holdings, and Sony Innovation Fund.
In what companies Japan Lifeline invested in?Japan Lifeline invested in AI Medical Service and Metcela.

See public comps similar to Japan Lifeline

Lists including Japan Lifeline

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial